Our Products
At GSK, we put your leadership skills to work in a way that maximizes your full potential as a person.
GlaxoSmithKline:
A global leader in dermatology
GSK recently acquired Stiefel Laboratories, the world’s largest independent dermatology company. GSK already has a presence in dermatology with products like Zovirax® and Bactroban®. With the addition of the Stiefel portfolio of products, we are a stronger,
more competitive driving force in dermatology around the world.
Stiefel has deep expertise in the research, development and formulation of dermatology
products that are highly regarded for quality and effectiveness. Stiefel products have the
respect and trust of dermatologists who want the best for their patients.
We are proud to deliver an even stronger portfolio of prescription, consumer, and
aesthetic skin health products to patients around the world. To learn more, visit www.stiefel.ca
What's New?
July 12, 2010
July 5, 2010
April 14, 2010
March 23, 2010
GSK’s commitment to operating with transparency in Canada
As a proud member of Canada’s Research Based Pharmaceutical Companies (Rx&D), GSK is committed to operating with transparency and to building trust in Canada. We believe in the value of building strong, effective stakeholder relationships and have undertaken several initiatives to demonstrate our commitment to transparency. Some of these initiatives include ending corporate political contributions, building more transparent stakeholder relations, and sharing our clinical trial registry.
>more
100% focused on HIV - Patient Centric - Committed to innovation
Established by GlaxoSmithKline and Pfizer, ViiV Healthcare is a specialist HIV company with a sustainable commitment to delivering advanced treatment and care, and improving access to medicines for people living with HIV worldwide.
Visit the ViiV Healthcare websiteGlaxoSmithKline recognized as one of the 50 Best Employers in Canada
Company marks third consecutive year as top pharmaceutical employer
GlaxoSmithKline Inc. (GSK) has once again been named one of the 50 Best Employers in Canada in the annual list published by The Globe and Mail's Report on Business Magazine.
"We are extremely proud to be recognized as a top employer in Canada for the eighth straight year," said Paul Lucas, President and CEO, GlaxoSmithKline Inc. "At GSK, we always strive to offer our employees a positive work environment where they can make a real and meaningful contribution to the wellbeing of their local community and to the health of people around the world."
Vaccines: Investing for Life
Vaccines help to protect people from disease, yet the search continues for vaccines that will halt the spread of cancer and diseases such as malaria and AIDS.
Research & Development
GlaxoSmithKline invested more than $178 million in Canadian research and development (R&D) in 2007 alone, ranking it among the top 15 contributors to R&D in Canada, across all industries.
